to assess the anatomical and functional changes after brolucizumab intravitreal injection (BIVI) in macular neovascularization type 1 (MNV1). Setting/Venue: Ophthalmology Clinic, University "G. d'Annunzio" of Chieti-Pescara.
Brolucizumab intravitreal injection in macular neovascularization type 1: VA, SD-OCT and OCTA parameters changes during a 16-weeks follow up
Toto, Lisa;Ruggeri, Maria Ludovica;D'Aloisio, Rossella;De Nicola, Chiara;Cerino, Luca;Di Marzio, Guido;Di Nicola, Marta;Porreca, Annamaria;Mastropasqua, Rodolfo
2022-01-01
Abstract
to assess the anatomical and functional changes after brolucizumab intravitreal injection (BIVI) in macular neovascularization type 1 (MNV1). Setting/Venue: Ophthalmology Clinic, University "G. d'Annunzio" of Chieti-Pescara.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
526851.pdf
accesso aperto
Dimensione
2.64 MB
Formato
Adobe PDF
|
2.64 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
